- Home
- / Rapid Micro Biosystems
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Rapid Micro Biosystems financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.1
2024-10-29
Market Capitalization
$46.3 M
2024-10-29
Revenue
$22.5 M
FY, 2023
CreditSafe Score
?
Score changed on Jan 22, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 23.2M | 17.1M | 22.5M |
| General and administrative expense | 17.9M | 26.8M | 24.9M |
| Operating expense total | 54.7M | ||
| EBIT | (47.2M) | (63.2M) | (56.6M) |
| EBIT margin, % | -369.0% | ||
| Interest expense | 1.8M | 4.2M | |
| Pre tax profit | (73.4M) | (61.4M) | (52.4M) |
| Income tax expense | 91.0K | (576.0K) | 31.0K |
| Net Income | (73.5M) | (60.8M) | (52.5M) |
| EPS | (1.4) | (1.0) |